Noxafil (posaconazole) is a small molecule pharmaceutical. Posaconazole was first approved as Noxafil on 2005-10-25. It is used to treat mycoses and oral candidiasis in the USA. It has been approved in Europe to treat aspergillosis, candidiasis, coccidioidomycosis, and mycoses. Noxafil's patents are valid until 2033-02-27 (FDA).
|Indication||aspergillosis, candidiasis, coccidioidomycosis, mycoses, oral candidiasis|
|Drug Class||Systemic antifungals (miconazole type)|